Quick Links
You are about to leave www.astellas.com and enter a third-party website. Astellas is not responsible for the content or services on the third-party website.
Would you like to continue?
Astellas is committed to providing timely and accurate information about our business, science and products. This section offers global resources for investors, journalists and media professionals. News and resources from our local affiliates can be viewed in the Local news section. If you are not an investor or journalist, click here.
TOKYO, July 20, 2020 – Astellas Pharma Inc. (President and CEO: Kenji Yasukawa, Ph.D., “Astellas”) today announced that it has been named to the FTSE4Good Index Series for ninth consecutive year. Astellas was recognized for its strong performance especially for the following categories: Climate Change, Labor Standards, and Corporate Governance.
The FTSE4Good Index Series, developed by FTSE Russell1, is designed to measure the performance of companies demonstrating strong Environmental, Social and Governance (ESG) practices. The FTSE4Good Indices are used by a wide variety of market participants to create and assess sustainable investment funds and other products.
In addition to the FTSE4Good Index Series, Astellas has been named to all ESG investment indices selected by the Government Pension Investment Fund of Japan which are FTSE Blossom Japan Index, MSCI Japan ESG Select Leaders Index, MSCI Japan Empowering Women Index (WIN), and S&P/JPX Carbon Efficient Index.
By fulfilling its corporate social responsibility as a pharmaceutical company, we will strive to continuously improve enterprise value.
Click below for a copy of the full press release
Follow us
